Clinical Trial Update: Integrated Treatment Program for Hypochondriasis in Primary Care Settings [Phase 3]

View source ↗

Summary

A Phase 3 trial of an integrated treatment program for hypochondriasis conducted in primary care has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypochondriasis
• Somatoform Disorders

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Hypochondriasis, Somatoform Disorders | Phase 3 | Status: COMPLETED